key: cord-0735198-ekzaxr0z authors: Agarwal, Neema; Jain, Payal; Khan, Tooba N.; Gupta, Rakesh title: Chest radiographic findings and their correlation with disease progression in COVID-19 patients in northern India date: 2022-02-16 journal: J Family Med Prim Care DOI: 10.4103/jfmpc.jfmpc_398_21 sha: 630d887c07ddebb5bb980055ad20a4b4dd8967f3 doc_id: 735198 cord_uid: ekzaxr0z INTRODUCTION: The present study was undertaken to describe and quantify the spectrum of radiographic findings on coronavirus disease 2019 (COVID-19) patients. The study also aimed to analyse the changes in chest X-ray (CXR) with disease progression. METHODS: COVID-19 patients admitted between the period of 15 March 2020 and 1 July 2020 were retrospectively enrolled. CXR images were assessed and reported as ‘Normal’ or ‘Abnormal’. A severity score was calculated using Warren et al.’s Radiographic Assessment of Lung Edema scoring. Correlations of the severity score thus calculated were sought with age, sex, clinical manifestations and presence of comorbidities. RESULTS: Five hundred patients (342 males, 158 females) were enrolled, median age being 35 years. Fever and cough were the most common symptoms but significant correlation of an abnormal CXR was found with dyspnoea. CXRs were normal in 67% and abnormal in 33% patients. The commonest comorbidities were diabetes mellitus and cardiovascular disease including hypertension, coronary artery disease and congestive heart failure. Predominant pattern was ground glass opacities, reticular alteration and consolidation peaking in the second week from symptom onset. The most frequent distribution was bilateral, peripheral with middle/lower predominance. Increasing age, male sex, presence of dyspnoea and comorbidities correlated with abnormal findings on CXR. Critical illness and mortality correlated strongly with increasing age, male sex and presence of dyspnoea, less so with presence of comorbidities. CONCLUSION: In the current scenario with clinicians and radiologists working in tandem, CXR seems to be a promising tool in providing relevant information in a simplified way. Introduction number of hospitalized patients and need for repeated evaluation places a huge burden on the radiology resources; this poses a big challenge for infection control in the CT suite and results in significant radiation exposure to the patients. Need for subsequent decontamination also disrupts the imaging services and often becomes a capacity constraint for patient management. The British Society of Thoracic Imaging has proposed a diagnostic algorithm for COVID-19 pandemic in March 2020 where it recommended chest X-ray (CXR) as the initial diagnostic imaging tool. [8] Around the same time, the American College of Radiology recommended use of CT only in specific clinical indications and not for screening COVID-19 patients. [9] In a developing country like ours, CT scanners are not ubiquitous, and chest radiographs are usually the first modality to investigate respiratory illnesses. Even in primary healthcare centres, establishing a clinical correlation with chest radiography would assist the primary care physicians in the management and decision making of COVID-19 patients. Since we are a tertiary care government-run hospital of the National Capital Region of India and acting as the Nodal centre for the disease, we are amongst the first few hospitals to encounter cases of COVID-19. COVID-19 shows a close relationship between pulmonary involvement and adverse clinical outcome. [10] The purpose of this study was to retrospectively study the extent, distribution and spectrum of radiographic findings in COVID-19 patients admitted to our hospital and to analyse the changes in CXR with disease progression. The study commenced after the approval of the Scientific Research Committee and Ethics Committee of our institute. The COVID-19 patients admitted to our hospital between the period of 15 March 2020 and 1 July 2020, who had a positive Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for SARS-CoV-2 from nasopharyngeal swab samples, were retrospectively enrolled. The pregnant patients were however excluded from our study. DICOM (Digital Imaging and Communications in Medicine) images of the CXR were assessed. It is worth mentioning here that at the time of writing this article, in India, as per our national guidelines all patients who tested positive for COVID-19 were to be hospitalized. All the CXRs were acquired as computed radiographs on a portable X-ray unit in the isolation wards. Posteroanterior projection was preferred for image acquisition, anteroposterior projection being used only when patient was too sick to be upright. Two radiologists scored each radiograph in consensus as 'Normal' or 'Abnormal'. The CXRs were assessed for abnormalities like consolidation, ground glass opacity (GGO), pleural fluid, cardiomegaly, lymphadenopathy and so on. A severity index was calculated by adapting and simplifying the Radiographic Assessment of Lung Edema score proposed by Warren et al. [11] A score of 0-4 was assigned to each lung depending on the extent of involvement by consolidation or GGO (0 = no involvement; 1 = <25%; 2 = 25-50%; 3 = 50-75%; 4 = >75% involvement). The scores for each lung were summed to produce the final 'Severity score'. Thus, the lowest score was '0' which represented a normal CXR and the highest score given was 8. The distribution of parenchymal involvement was categorized into (i) peripheral predominance, perihilar predominance (peripheral and perihilar demarcation was defined as halfway between lateral edge of the lung and hilum), or neither; (ii) right, left or bilateral lung involvement; and (iii) upper zone, mid zone, lower zone or no zonal predominance. Correlations of patient characteristics like age, sex, clinical features and comorbidities were sought with normal or abnormal CXR. When correlating the severity score with above-mentioned patient characteristics, in patients who underwent more than one CXR, the highest severity score was considered for analysis (maximum ever during hospital stay as per the serial CXRs). The common pattern of evolution of findings on CXR over time was also described. The data are presented as the number (%) or the median because the age of the patients and the CXR score were not normally distributed. The Mann-Whitney U test and multiple correlation coefficient were used to find relation between abnormal CXRs, their severity index in relation to age of the patient, underlying comorbidities and common symptoms. In our study, 500 patients were included with positive RT-PCR for COVID-19 between 15 March 2020 and 1 July 2020, who underwent CXR for evaluation. Of the total 500 patients, 342 were males (68.4%) and 158 (31.6%) females. The median age in our study subjects was 35 years ranging between 3 and 82 years [ Table 1 ]. Forty-one patients were asymptomatic while remaining 459 patients who were symptomatic had fever and cough as the most common symptoms presenting in 280 (56%) and 270 (54%) patients, respectively. Other symptoms recorded were dyspnoea, sore throat, myalgia, diarrhoea, headache, anosmia, nausea, dizziness and loss of appetite in decreasing order of frequency. The commonest comorbidity in our study was found to be diabetes mellitus (DM) followed by cardiovascular diseases (CVD) comprising hypertension (HTN), coronary artery disease (CAD) and congestive heart failure [ Table 1 ]. In our study, the CXRs of 335 (67%) out of 500 patients were found to be normal. Of the remaining 165 (33%) patients whose CXRs were abnormal, predominant parenchymal abnormality encountered was GGOs followed by reticular alteration and consolidation, patchy or lobar. Bilateral involvement, peripheral and mid or lower zonal predominance were seen commonly [Images 4 and 5]. Other findings though less frequent were pleural effusion and lymphadenopathy [ Table 2 ]. The percentage of abnormal CXR was higher in males as compared to females [ Table 3 ]. On using the Mann-Whitney U test, there was found to be a no significant difference in severity between CXR of males and females (P-value is 0.968). It was also observed that the percentage of abnormal CXR increased significantly in patients above 40 years of age [ Table 4 and Image 1]. The average age of patients having abnormal CXRs was 46.9 years and median age to be 46 years. One or more comorbidities were present in 126 (25.2%) of our sample population of COVID-19 patients, comprising 78 males and 48 females. The most prevalent comorbidity observed was DM (14.8%), followed by HTN (12.2%). Multiple correlation coefficient test was used to establish correlation of abnormal CXRs with presence of comorbidities, which revealed a high positive correlation with the coefficient of correlation being 0.99. CVD showed maximum correlation with abnormal CXR (coefficient of correlation 0.98 with P value as 0), followed by chronic obstructive pulmonary disease and DM. Likewise, there was found to be a positive correlation between presence of comorbidities and increased severity score of CXRs, with the coefficient of correlation being 0.63 (P-value < 0.05). When seeking a relation between presence of symptoms and an abnormal CXR, a moderate positive correlation was observed with the coefficient of correlation being 0.53. Though fever was the commonest recorded symptom, maximum correlation of an abnormal CXR was found to be with dyspnoea where the coefficient of correlation was 0.478 which is a moderately strong correlation. In our data set, there were 77 patients who had subnormal arterial oxygen saturation (<90% on room air) and required supplemental oxygen. In this subset of 77 patients, 69 had abnormal CXRs (89.6%) which is much higher vis-à-vis in the overall data set (33%). The average as well as mean age of this subset of patients was 48 years as opposed to 35 years in the overall data set [ Table 5 ]. Amongst symptoms in this data set, the coefficient of correlation between CXR being abnormal is highest (0.56) with dyspnoea followed by anosmia and cough. The same holds good when correlations are sought with severity indices. In our overall data set, the correlation between abnormal CXR and presence of comorbidities is very high; however, the same did not hold good for this critical subset of patients. At the same time, this subset showed a weak positive correlation of severity score of CXR with presence of comorbidities. Total of 852 CXRs were evaluated of the 500 patients included in the study. The evolution of CXR findings were studied from the day of symptom onset (considered as day 1 of illness). It was observed that in 1-7 days after symptom onset, there is rapid progression of findings. In this phase though GGO was the commonest abnormality, reticular alteration was also commonly encountered, frank consolidation being relatively rare. From 8-14 days, the lung involvement showed maximum severity scores [ Table 6 and Image 6]. Though GGO and reticular pattern was still common, consolidation increased. During this period, asynchronous and mixed pattern of involvement was commonly observed. After 14 days, the severity scores started to decline with decrease in the reticular opacities and consolidation. However, GGO was again observed as the most common finding. In severe cases, this decline was more prominent during the third week of illness. Even on discharge in few patients, the most common residual abnormality observed was GGO. It was also observed that the average severity scores were higher in the critical subset of 77 patients as compared to the total sample of 500 patients [ Table 6 , Images 2 and 3]. We hereby report a study of 500 patients admitted to our hospital with RT-PCR confirmed SARS-CoV-2 infection. This is one of the first few studies to explore the CXR findings in SARS-CoV-2 positive cases in the Indian population to give a peek into the radiographic distribution, frequency and severity. Out of 500 patients, 335 (67%) had normal CXR while 165 (33%) were abnormal. We had a total of 459 symptomatic patients, out of which 161 had abnormal findings on CXR. Forty-one patients in our study were asymptomatic throughout their hospital stay, out of which only four had abnormal CXR. Similar results were reported in a study done by Weinstock et al. [12] where they found 58.3% CXR to be normal in 636 symptomatic patients. Another study by Vancheri et al. [13] comprising 240 symptomatic patients also described 25% CXRs to be normal. In our study, distribution of findings on abnormal CXR was predominantly bilateral, peripheral and lower zonal. This corroborates with other similar studies done worldwide. [13, 14] We found GGOs to be by far the most common parenchymal abnormality seen in 116 patients (70%) followed by reticular opacities in 85 (51%) and consolidation in 52 (31%), while pleural effusion (4%) and lymphadenopathy (2%) were found in only a few patients. Weinstock et al. [12] reported interstitial and GGOs to be the prominent descriptive findings in CXR. Vancheri et al., [13] Shi et al. [14] and Zhao et al. [15] also described GGOs as the most common abnormality on chest imaging. In the Indian context, a recent study also echoed our findings. [16] However, in a study done by Wong et al., [17] the most common finding reported was consolidation followed by GGO. Our study comprised 342 male and 158 female confirmed COVID-19 patients, thus showing a male preponderance. Most of the studies conducted worldwide have shown similar trends of males being more prone for infection. [18] Out of the 165 patients with abnormal CXRs, 74% were males and 26% females. However, no statistically significant difference was found in severity indices between males and females. The percentage of abnormal CXRs increased significantly in patients above 40 years of age. We also found a strong correlation between presence of comorbidities and an abnormal CXR. The severity on CXRs was also seen to correlate positively with presence of comorbidities. Out of the major comorbidities in our study, CVD (comprising HTN, CAD and CHD) showed maximum correlation with abnormal CXR. Similar findings were also reported in other international and national studies. [19] [20] [21] Out of the total symptomatic patients, fever (56%) and cough (54%) were the most common presenting manifestations, followed by dyspnoea, sore throat and myalgia. The clinical presentation of COVID-19 as reported by various studies conducted document similar symptoms in patients. [19, 20, 22] Another important observation was that presence of symptoms correlated well with CXR. Though fever and cough were the most common recorded symptoms, maximum correlation of an abnormal CXR was found to be with dyspnoea which was recorded in 133 patients (26.6%). We could not find sufficient literature on the correlation of abnormal CXR with dyspnoea in COVID-19. In our study, there were 76 patients who had a fall in arterial oxygen saturation and required admission or transfer to intensive care unit (ICU). The mean age of these sick patients was higher, that is 48 years as opposed to 35 years in the overall sample. Out of the patients who were managed in ICU, eight patients succumbed to COVID-19-related illness, out of which seven were males and their mean age was 56.5 years. Multiple recent studies document older age and male sex to be associated with increased disease severity and mortality. [19, 20, 22] The average CXR severity score of these 76 patients was higher than that of the overall sample, thus establishing an association of CXR severity with the severity of disease in our study. In this subset of patients, the percentage of abnormal CXRs was much higher (89.6%) as compared to that found in the total sample (33%). The seven patients in this subset had normal CXRs that could not be explained by plain radiography alone and CT was not available. Thus, the possibility of false-negative CXR cannot be ruled out in these seven patients. The most recent literature documents sensitivity of CXR to vary between 69% and 90%. [23] Forty-two patients out of 76 who required ICU admissions had one or more baseline comorbidities like DM, HTN, thyroid disorders and so on. Five out of the eight who died also had underlying comorbid illnesses. However, presence of comorbidities was not found to be strongly associated with critical illness. Most of the recent literature in this context suggest association of underlying comorbidities with critical illness and mortality. [19] [20] [21] [22] [23] However, a large study from New York concluded comorbidities to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with COVID-19. [24] From the evolution of CXR findings with the course of the disease, we inferred that COVID-19 initially involved both lung parenchyma and lung interstitium, manifesting as GGO, GGO plus consolidation or GGO plus reticular pattern, causing single or multiple abnormalities simultaneously. As the disease progressed, both the parenchymal and interstitial abnormalities progressed, GGO turned into GGO plus reticular pattern and GGO plus reticular pattern turned into consolidation. Meanwhile, some lesions began to absorb. Thereafter, the intensity of the previous abnormalities decreased. Thus, our study highlights the role of chest radiograph and its severity scoring in determining the disease severity. This becomes even more relevant in areas with limited resources. [25] These findings also correlated well with the recent studies carried out worldwide. [13, [26] [27] [28] A recent European study which compared chest radiography and CT chest in triage setting of COVID-19 patients also concluded that clinical triage is safely assisted by CXR. [29] Our study had few limitations. First, review CXRs were decided by the clinical need and was not uniform, thus may have affected the precision of our analysis. Second, CT was not available, thus limiting evaluation of the sensitivity and specificity of CXR, and the possibility of the normal CXRs having subtle abnormalities cannot be completely ruled out. Third, as no confirmation of the findings was done by lung biopsy, other potential causes of GGO, such as pulmonary haemorrhage, could not be investigated. Fourth, although radiologists were instructed not to let the diagnosis of COVID-19 influence their interpretation, yet some possibility remains. Conclusion COVID-19 pneumonia manifested on CXRs as GGOs, reticular alteration and consolidation causing single or multiple abnormalities simultaneously, which peaked in the second week from symptom onset. The most frequent distribution was bilateral, peripheral with middle/lower predominance. Increasing age, male sex, presence of dyspnoea and presence of comorbidities correlated well with increasing abnormal findings on CXR in COVID-19 patients. Elderly males having dyspnoea and hypoxemia were more likely to be admitted in ICU. Critical illness and mortality correlated strongly with increasing age, male sex and presence of dyspnoea, less so with presence of comorbid conditions. Chest radiography is a useful, ubiquitously available tool in a hospital setting that can assess the severity of the COVID-19 pneumonia in a simplified way correlating well with an increased risk of ICU admission or progression to critical illness. This also goes a long way in aiding the primary care physicians who are the first level of medical care for majority of Indian population. Thus, it is imperative for every radiologist and clinician to be familiar with the radiographic features and act in tandem to fight this tiring battle of the ongoing pandemic. CXR has emerged as the initial imaging tool to assess the severity of the COVID-19 pneumonia in a simplified way. It is ubiquitously available even in the settings where there is a dearth of resources and at the same time correlates well with progression to critical illness. Understanding of COVID-19 based on current evidence COVID-19 Dashboard by the Center for Systems Science and Engineering Johns Hopkins University. Retrieved Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19) Coronavirus disease 2019 (COVID-19): A perspective from China A British Society of Thoracic Imaging statement: Considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic CT) for Suspected COVID-19 Infection American College of Radiology COVID-19 outbreak in Italy: Experimental chest X-ray scoring system for quantifying and monitoring disease progression Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS Chest x-ray findings in 636 ambulatory patients with COVID-19 presenting to an urgent care center: A normal chest x-ray is no guarantee Radiographic findings in 240 patients with COVID-19 pneumonia: Time-dependence after the onset of symptoms Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study Clinico-radiological evaluation and correlation of CT chest images with progress of disease in COVID-19 patients Frequency and distribution of chest radiographic findings in patients positive for COVID-19 Individualizing risk prediction for positive coronavirus disease 2019 testing: Results from 11,672 patients Characteristics, treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit Chest X-ray in new coronavirus disease 2019 (COVID-19) infection: Findings and correlation with clinical outcome Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease Modified chest X-ray scoring system in evaluating severity of COVID-19 patient in Dr. Soetomo General Hospital Surabaya, Indonesia Imaging features and evolution on CT in 100 COVID-19 pneumonia patients in Wuhan, China Chest CT findings of COVID-19 pneumonia by duration of symptoms Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: A longitudinal study Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting The authors would like to acknowledge Mr. Praveen Soneja for carrying out the statistical analysis and rendering support in manuscript preparation. The authors certify that above-mentioned approvals were duly taken before commencement of the study. Nil. There are no conflicts of interest.